Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (86K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Kamiya, H.
Right arrow Articles by Kasai, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamiya, H.
Right arrow Articles by Kasai, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research Pages 2611-2617  


The (6-4) photoproduct of thymine-thymine induces targeted substitution mutations in mammalian cells
Introduction
Materials And Methods
   Materials
   Oligonucleotide synthesis
   Construction of parental vectors
   Construction of vectors containing T(6-4)T and T=T, and DNA transfection into COS-7 cells
   Calculation of cytotoxicity in COS-7 cells
   Mutant screening and sequencing
   Calculation of mutation frequency
Results
   Vectors
   Cytotoxicity of T(6-4)T and T=T in COS-7 cells
   T(6-4)T and T=T are mutagenic in mammalian cells
   Mutation spectra of photolesions in COS-7 cells
   Large deletions induced by T(6-4)T and T=T
Discussion
Acknowledgements
References


The (6-4) photoproduct of thymine-thymine induces targeted substitution mutations in mammalian cells

The (6-4) photoproduct of thymine-thymine induces targeted substitution mutations in mammalian cells

Hiroyuki Kamiya*, Shigenori Iwai1, Hiroshi Kasai

Department of Environmental Oncology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan and 1Biomolecular Engineering Research Institute, 6-2-3 Furuedai, Suita, Osaka 565-0874, Japan

Received February 20, 1998; Revised and Accepted April 17, 1998

ABSTRACT

Two major ultraviolet-induced photolesions of TpT, a (6-4) photoproduct [T(6-4)T] and a cis-syn cyclobutane TT dimer (T=T), were incorporated into a predetermined site of one of the leading and lagging template strands of a double-stranded vector, and the modified DNAs were transfected into simian COS-7 cells. The DNAs replicated in the cells were recovered and were transfected again into Escherichia coli. The DNA replication efficiencies of plasmids containing T(6-4)T and T=T in the template strand for lagging strand synthesis were 93 and 79%, respectively, as compared with the unmodified DNA. Similar inhibitory effects were observed in the cases of the photoproducts in the template strand for leading strand synthesis (71 and 58%, respectively). These results indicated that T(6-4)T blocked DNA replication more weakly than T=T during leading and lagging strand syntheses in mammalian cells. The mutation frequencies of T(6-4)T were 2.3 and 4.7% in the leading and lagging template strands, respectively. The T=T lesion was less mutagenic and induced mutations with 0.2-0.7% frequencies. The T(6-4)T lesion primarily elicited 3[prime]-T->C substitutions, and T=T induced various types of mutations. These results indicate that T(6-4)T is more mutagenic than T=T during leading and lagging strand syntheses in simian cells. Moreover, this is the first evidence that shows T(6-4)T mainly elicits targeted substitutions at its 3[prime]-T site in mammalian cells.

INTRODUCTION

DNA damage caused by exposure to ultraviolet (UV) light appears to be involved in the process of skin cancer, through the mutagenic activation of proto-oncogenes and/or the inactivation of tumor suppressor genes (1-10). Two major types of photolesions are formed by UV light at adjacent pyrimidine sites in DNA: cis-syn cyclobutane-type pyrimidine dimers and pyrimidine(6-4)-pyrimidone photoproducts (11). The (6-4) photoproducts are formed 3-5-fold less frequently than the cis-syn cyclobutane-type pyrimidine dimers by UV light, and by simulated and natural sunlight (12-14).

We previously reported the mutation spectrum of cis-syn cyclobutane thymine dimer (T=T) at a hot spot of a c-Ha-ras gene on chromosomal DNA in mouse cells (15). Although this is the first report of the mutagenicity of T=T in a defined sequence in mammalian cells, the results obtained were semi-quantitative, because the activation of the gene by amino acid substitutions was employed as the selection pressure. Gentil et al. recently reported the mutagenicity of pyrimidine-pyrimidone (6-4) photoproduct of thymine-thymine [T(6-4)T] in addition to T=T on single-stranded (ss) vectors in mammalian cells (16). However, rare opportunities of lesion repair on ss DNA before replication may lead to higher mutation frequency (MF) as compared with mutational events that actually occur in cells. Also, an intermediate in the repair process of the lesions may contribute to the mutation event, and this putative effect on the mutation spectra may be ignored with ss vectors. Thus, it is very important to reveal the mutational properties of T(6-4)T and T=T in double-stranded (ds) DNA, in order to assess the biological effects of the photolesions, while considering their repair efficiencies.

Another objective of this study is to compare the mutational properties of the two photolesions during leading and lagging strand syntheses. The effects of DNA adducts on replication during leading and lagging strand syntheses have been reported in Escherichia coli (17-19), by the use of SV40 origin-dependent in vitro replication (20-22), and in mammalian cells (23-25). To our knowledge, our previous work (25) is the only report that demonstrated the effects of the leading and lagging strand apparatuses on translesional DNA synthesis opposite a chemically defined lesion in mammalian cells. Thus, it is important to investigate the effects of bulky DNA lesions on replication during leading and lagging strand syntheses.

To study the frequency and the spectrum of mutations induced by the two major photolesions in mammalian cells, we incorporated T(6-4)T and T=T into unique, predetermined sites in ds vectors. The lesions were located in either the leading or the lagging template strand, and the mutational properties were investigated with simian COS-7 cells. We observed that (i) T(6-4)T blocked DNA replication more weakly than T=T during leading and lagging strand syntheses. We found that (ii) T(6-4)T was more mutagenic than T=T in COS-7 cells, and that (iii) T(6-4)T induced targeted substitution mutations at the 3[prime]-T position. Moreover, we revealed that (iv) the mutation frequencies and spectra elicited by these photoproducts were affected by the strand within which the base was located.

MATERIALS AND METHODS

Materials

COS-7 cells were from the RIKEN Cell Bank (Tsukuba, Japan). Escherichia coli strain DH5[alpha] cells [F -, [phis]80d lacZ[Delta]M15 [Delta] (lacZYA-argF) U169, endA1, recA1, hsdS17 (rK-mK+), deoR, thi-1, supE44, [lambda]-, gyrA96, relA1] for CaCl2 transformation were prepared according to the method described in the literature (26).

Oligonucleotide synthesis

Oligonucleotides containing T(6-4)T and T=T were synthesized by the solid phase phosphoramidite method as described previously (27,28), and were purified essentially as described (19). The fragment containing T(6-4)T was purified with slight modifications. Namely, the acetic acid treatment of the oligonucleotide was omitted to avoid degradation. Instead, an acetic triethylammonium solution was added, and both evaporation and subsequent co-evaporation with water were conducted. During these procedures, the dimethoxytrityl protecting group was removed. The oligonucleotides synthesized were 5[prime]-dGGTCGACTTAAGGTACC-3[prime], where either T(6-4)T or T=T was incorporated into the underlined position. The unmodified oligonucleotide (TT is not a photodimer) for the control experiment and the splint 25mer (5[prime]-dAATTGGTACCTTAAGTCGACCGGCC-3[prime]) were prepared as described (19). These oligonucleotides were eluted as a sharp single peak in both reverse-phase and anion-exchange HPLCs (data not shown). Other oligonucleotides were purchased from Hokkaido System Science Co. (Sapporo, Japan) in purified forms.

Construction of parental vectors

Plasmid pSVK3 (Pharmacia Biotech Inc.) was digested with SspI and PvuII. The largest fragment, containing the ampicillin resistance gene and the ColE1 origin, was ligated with a linker DNA to introduce HindIII, SphI and EcoRI sites. The product of a HindIII-SphI digest of this plasmid was ligated with the HindIII-SphI fragment containing the SV40 origin, which was prepared from pMY189 (29). Another linker DNA was inserted into the EcoRI site to introduce an ApaI site. The vectors thus obtained were designated as pSVKAM2-AE and pSVKAM2-EA, depending on the orientation of the ApaI and EcoRI sites (Fig. 1).


Figure 1. (A) Structure and partial nucleotide sequence of pSVKAM2, the parental shuttle vector. The SV40 origin and the ColE1 origin, which work in COS-7 cells and E.coli, respectively, and the E.coli ampicillin resistance gene are shown. (B) Ds oligonucleotides with either T(6-4)T or T=T inserted into the vector pSVKAM2. The oligonucleotides contain ends that are compatible with the restriction enzyme-cleaved ends within the cloning site. Closed circles represent 5[prime]-phosphate groups. The TT with asterisks indicates the position where either of the photolesion or the unmodified TpT was incorporated. (C) Schematic presentation of the replication of template strands containing T(6-4)T or T=T. The triangle represents the photolesion.


Construction of vectors containing T(6-4)T and T=T, and DNA transfection into COS-7 cells

Ds vectors were constructed as described (19). The constructed ds vectors (4 ng) were transfected into the cultured COS-7 cells by using Lipofectamine (Life Technologies, Inc.), essentially as described previously (25). After 48 h, the plasmid amplified in COS-7 cells was recovered by the method of Stary and Sarasin (30). The recovered DNA was treated with DpnI to digest the unreplicated plasmids. After the removal of the proteins by passage through a Probind (Millipore Co.) the DNA was purified by ethanol precipitation.

Calculation of cytotoxicity in COS-7 cells

Escherichia coli DH5[alpha] cells were transfected with the recovered plasmid by the calcium chloride method (26). To measure the cytotoxicity, a small portion of the recovered DNA was used. The numbers of bacterial colonies were used for the calculation of the cytotoxicities in COS-7 cells.

Mutant screening and sequencing

The plasmid recovered from the COS-7 cells was digested with AflII under the conditions recommended by the supplier. The treated DNA was transfected into E.coli strain DH5[alpha] to obtain a `mutant' pool. Untreated DNA in the same buffer solution was also transfected, and the ratio of (colonies obtained with treated DNA) to (colonies obtained with untreated DNA) was calculated. This value (defined as A) was used for the calculation of the MF, as described below.

The plasmid DNA was isolated by the alkaline lysis method (26) from each colony in the `mutant' pool. Each plasmid DNA was screened by dot blot hybridization, using either the unmodified 17mer or the splint 25mer as a probe (19). The plasmids that were judged as mutants by this hybridization experiment were treated with the targeted restriction enzyme, AflII, and the lack of cleavage was confirmed.

The nucleotide sequences of the mutants were analyzed by plasmid sequencing with the primer (5[prime]-dAAAAAAGGGAATAAGGGCGA-3[prime]) and either the ABI PRISM Dye Terminator Cycle Sequencing Kit (Perkin-Elmer) or the Thermo Sequenase Dye Terminator Cycle Sequencing Kit (Amersham), with an Applied Biosystems model 373S DNA sequencer (Perkin-Elmer).

Calculation of mutation frequency

Through the screening by hybridization and the subsequent sequencing, the plasmids in the `mutant' pool that were obtained from the AflII-treated plasmid fraction were divided into three categories: (i) plasmids with a mutation(s) in the AflII site, (ii) uncleaved, non-mutant plasmids, and (iii) plasmids containing a large (>4 bp) deletion. The plasmids in the first two groups and the cleaved fraction were judged as effective. In this study, we judged mutations in the 5[prime]-CTTA sequence (the dimer site and the two flanking positions) as actual mutations. The MF, (mutant colonies) / (effective colonies), was calculated as follows:
MF = (A × B) / (1 - A × C)
where A = (colonies obtained with digested DNA) / (colonies obtained with untreated DNA); B = (mutant colonies) / (colonies screened from the mutant pool); C = (colonies with a large deletion) / (colonies screened from the `mutant' pool); 1 - A × C = the ratio of effective colonies.

RESULTS

Vectors

We previously used a site-specific mutagenesis approach to investigate the mutational properties of oxidized adenine in mammalian cells (25). We selected mutated plasmid molecules that were resistant to a restriction enzyme. In that study, we observed that most of the resistant plasmids contained random deletions (~10% of the total population). Thus, it is necessary to minimize this error-prone replication in mammalian cells (31,32) to select the mutant plasmids that are resistant to a restriction enzyme. Moreover, whether a DNA lesion induces deletions around itself during replication is another important question to be resolved. Therefore, we constructed new vectors in which the targeted site is located between two essential sites, the SV40 origin and the ampicillin resistance gene, to minimize the random deletions (Fig. 1A).

The (+)-strand of pSVKAM2 [we define the (+)-strand as the same strand of ss pSVK3 (the parental vector of pSVKAM2) that is produced by the infection of helper phage] is replicated during lagging strand synthesis around the region where the linker DNA with a photolesion was inserted (Fig. 1B and C). Accordingly, the (-)-strand of pSVK3 around the inserted site is replicated by the leading strand apparatus. Ds vectors with a photolesion were constructed by the insertion of ds oligonucleotides by the use of the ApaI and EcoRI sites (Fig. 1B).

We used the following nomenclature: (+)-T(6-4)T and (+)-T=T as the vectors containing T(6-4)T and T=T, respectively, in the (+)-strand. The (+)-control vector has the same sequence with an unmodified TpT instead of a photolesion. The (-)-T(6-4)T, (-)-T=T, and (-)-control are named similarly, although the strand of interest is the (-)-strand (Fig. 1).

Cytotoxicity of T(6-4)T and T=T in COS-7 cells

We first evaluated the cytotoxicities of T(6-4)T and T=T in COS-7 cells to determine the degree of the replication block. As preliminary experiments, we transfected various amounts of the pSVKAM2 vector into COS-7 cells and the plasmids recovered from the cells were transfected into E.coli DH5[alpha] cells. We observed that the number of E.coli colonies and the amount of DNA transfected into COS-7 cells exhibited a linear correlation between 0 and 5 ng under our conditions (data not shown). This means that the number of bacterial colonies reflects the relative amount of plasmid DNA replicated in COS-7 cells. Thus, the number of E.coli colonies was a good indicator for the evaluation of the photolesion cytotoxicity in COS cells.

Four ng of the modified and unmodified vectors were transfected into COS-7 cells and were allowed to replicate in the cells. The plasmid DNAs recovered from the cells were transfected into E.coli DH5[alpha] cells and the colonies formed were counted. The number of E.coli colonies derived from (+)-T(6-4)T was 93% of the (+)-control (Table 1). On the other hand, the number of E.coli colonies derived from (+)-T=T was 79% of the control (Table 1). Since the photolesions in the (+)-vector were located on the template strand of lagging strand synthesis (Fig. 1C), these results mean that the two photodimers weakly blocked the lagging strand synthesis. Similarly, the relative replication efficiencies of (-)-T(6-4)T and (-)-T=T were estimated to be 71 and 58%, respectively (Table 1). These results suggest that T=T is more cytotoxic than T(6-4)T during either leading or lagging strand synthesis. Moreover, the degree of the replication block by either photolesion is higher during leading strand synthesis than during lagging strand synthesis.

T(6-4)T and T=T are mutagenic in mammalian cells

We introduced the photolesions into a unique restriction enzyme site (5[prime]-CTTAAG, an AflII site), and thus we could select mutants as bacterial cells with a plasmid resistant to the restriction enzyme. The AflII treatment was carried out for the plasmids recovered from the transfected COS-7 cells, and the digested DNAs were introduced into E.coli. The hybridization experiment was employed to discriminate mutated and normal sequences, and to remove `mutants' that contained a large (>4 bp) deletion. By these techniques, we selected plasmids mutated within the AflII site.

Table 1. Cytotoxicities of photolesions in COS-7 cellsa
Vector Double strand (+)
lagging
Double strand (-)
leading
unmodified 100b 100b
T(6-4)T 93 71
T=T 79 58
aPercentage of colonies resulting from transformation of E.coli DH5[alpha] cells with the plasmid DNA recovered from COS-7 cells. The values represent the average of six separate experiments.
bThis value is defined as 100 for each experiment. The actual number of colonies ranged between 1000 and 3000.

Table 2. Mutation frequencies of photolesions in COS-7 cellsa
Vector Double strand (+)
lagging
Double strand (-)
leading
unmodified 0.11 0.01
T(6-4)T 4.70 2.30
T=T 0.68 0.20
aPercentage of colonies containing a plasmid mutated within the 5[prime]-CTTA sequence. Mutants containing a large (>4 bp) deletion are excluded in the calculation as described in Materials and Methods. The values represent the average of three separate experiments.

As shown Table 2, the two photolesions induced mutations in mammalian cells. The T(6-4)T lesion in the (+)-DNA induced mutations with an efficiency of 4.70%. The maximum MF was expected to be 50%, because the complementary strand is also replicated. Thus, at least 9.40% of the photoproducts were estimated to induce the misincorporation of nucleotides during lagging strand synthesis. On the other hand, the MF of T=T was 0.68% during lagging strand synthesis (Table 2).

The T(6-4)T and T=T lesions in the ds (-)-vectors induced mutations with efficiencies of 2.30 and 0.20%, respectively (Table 2). The fact that the MFs of these photolesions in different strands were not identical indicates that the ratios of misincorporation were affected by the leading or lagging strand synthesis during replication.

Mutation spectra of photolesions in COS-7 cells

We analyzed the sequences of the mutants obtained with the (+)-T(6-4)T. The mutation detected most frequently was a 3[prime]-T->C transition (17 colonies, Table 3). This result indicates that dGMP was incorporated opposite the 3[prime]-T of T(6-4)T. Transversions of the 3[prime]-T were also elicited during lagging strand synthesis (eight colonies). A similar mutation spectrum was observed with T(6-4)T in the (-)-strand, during leading strand synthesis (Table 3). However, the ratio of colonies with the 3[prime]-T->C transition was lower than that during lagging strand synthesis, and no 3[prime]-T->G transversions appeared to be elicited during leading strand synthesis. An interesting feature was that C->T transitions occurred at the 5[prime]-flanking position of T(6-4)T during leading strand synthesis. This phenomenon was not observed during lagging strand synthesis.

Table 3. Mutations induced by T(6-4)T in COS-7 cellsa
Sequenceb Vector
  double strand (+)
lagging
double strand (-)
leading
5[prime]-TC-3[prime] 17 (65) 10 (50)
5[prime]-TG-3[prime] 3 (12) 0 (0)
5[prime]-TA-3[prime] 5 (19) 4 (20)
5[prime]-CT-3[prime] 1 (4) 1 (5)
5[prime]-GT-3[prime] 0 (0) 1 (5)
5[prime]-AT-3[prime] 0 (0) 0 (0)
Others 0 (0) 4 (20)c
aNumber of mutants observed in three separate experiments. Percentage of each targeted mutation is represented in parentheses.
bMutated sites are indicated by underlines.
cThe C residue at the 5[prime]-flanking position of TT changed to T (5[prime]-CTTA to TTTA).

Table 4. Mutations induced by T=T in COS-7 cellsa
Sequenceb Vector
  double strand (+)
lagging
double strand (-)
leading
5[prime]-TC-3[prime] 6 (19) 4 (17)
5[prime]-TG-3[prime] 7 (23) 2 (8)
5[prime]-TA-3[prime] 1 (3) 1 (4)
5[prime]-CT-3[prime] 4 (13) 2 (8)
5[prime]-GT-3[prime] 2 (6) 2 (8)
5[prime]-AT-3[prime] 2 (6) 3 (13)
5[prime]-AC-3[prime] 1 (3) 3(13)
[Delta]T 2 (6)c 2(8)
[Delta]TT 0 (0) 1(4)e
+A 0 (0) 2(8)f
Others 6 (19)d 2 (8)g
aNumber of mutants observed in three separate experiments. Percentage of each targeted mutation is represented in parentheses.
bMutated sites are indicated by underlines.
cOne clone has a sequence deleted at C in addition to T (5[prime]-CTTA to TA).
dOne clone has a 5[prime]-GTTA sequence and four clones have a 5[prime]-CTTT sequence. One clone has a sequence deleted at A (5[prime]-CTTA to CTT).
eThis clone has a sequence deleted at C in addition to TT (5[prime]-CTTA to A).
fThese clones have a 5[prime]-CTATA sequence.
gOne clone has a 5[prime]-GTTA sequence and one clone has a 5[prime]-CTTT sequence.

Large deletions induced by T(6-4)T and T=T

We compared the percentage of large (>4 bp) deletions induced by the two photolesions. Large deletions occurred in 1.7-1.8% of the cases of vectors containing T(6-4)T (Table 5). The T=T lesion elicited deletions with a frequency of 2.0 and 1.3% during lagging and leading strand syntheses, respectively. On the other hand, deletions occurred in only 0.4% of the unmodified vectors. Thus, it appeared that the two photodimers induced deletion mutations. Moreover, the frequencies of the deletions were higher in the vector containing T=T in the (+)-strand than that containing T=T in the (-)-strand. This result suggests that the deletion mutations occurred more frequently during lagging strand synthesis than during leading strand synthesis with T=T. However, the frequencies of the induced deletions were similar in the case of T(6-4)T.

Table 5. Deletion frequencies of photolesions in COS-7 cellsa
Vector Double strand (+)
lagging
Double strand (-)
leading
unmodified 0.39 0.41
T(6-4)T 1.74 1.81
T=T 1.96 1.28
aPercentage of colonies containing a large (>4 bp) deletion to total E.coli colonies. The values represent the average of three separate experiments.

DISCUSSION

We have used a site-specific mutagenesis approach to investigate the mutational properties of the two photolesions, T(6-4)T and T=T, in mammalian cells. The two major aims were to investigate the mutational properties of T(6-4)T and T=T in ds DNA and to compare the effects of the photolesions on replication by leading and lagging strand replication proteins in mammalian cells.

We found that the replication efficiencies of the vectors containing T=T were lower than those of the vectors with T(6-4)T (Table 1). These results indicate that T(6-4)T blocks DNA replication more weakly than T=T. It has been reported that the repair of (6-4)photoproducts is more rapid than that of cyclobutane dimers (12,13,33-35). Moreover, it was shown that human cell extracts repair T(6-4)T more rapidly than T=T, using ds DNA containing each of the photoproducts (36). The weaker replication block by T(6-4)T may be due to its more rapid repair, at least in part. In accordance with these findings, Thomas and Kunkel reported that cyclobutane pyrimidine dimers are responsible for the inhibition of replication conducted by human cell extracts with UV-irradiated DNA (37). The same conclusion was achieved by Carty et al. by the use of human and monkey cell extracts (38).

The mutation frequencies of T(6-4)T were 4.70 and 2.30% with (+)- and (-)-T(6-4)T, respectively (Table 2). On the other hand, (+)- and (-)-T=T induced mutations at frequencies of 0.68 and 0.20%, respectively (Table 2). Obviously, T(6-4)T was more mutagenic than T=T in mammalian cells. The MF of small lesions, such as 8-hydroxyguanine and 2-hydroxyadenine, in ds DNA is between 0.1 and 1% (25,39,40). Thus, T(6-4)T is a highly mutagenic lesion.

The mutation found most frequently was a 3[prime]-T->C transition with T(6-4)T (Table 3). This type of mutation is found as the major mutation induced by T(6-4)T in yeast and SOS-induced bacteria (41-43). Thus, it is shown for the first time that the mutation spectra of T(6-4)T in the cells of three different organisms (E.coli, yeast and mammals) are coincident. It was reported that a duplex containing a Gua base opposite the 3[prime]-T of T(6-4)T is thermodynamically more stable than oligonucleotides containing other pairs involving the 3[prime]-T of T(6-4)T (44). The 3[prime]-T->C transition observed in our present study can be explained by this base pair formation. Transversion mutations were also detected at the 3[prime]-T site, although 3[prime]-T->G mutations were not detected with (-)-T(6-4)T (Table 3). Thus, the 3[prime]-T was the primary target site of the mutations induced by T(6-4)T. In contrast, fewer mutations were found at the 5[prime]-T of T(6-4)T (Table 3). Interestingly, C->T transitions at the 5[prime]-flanking position of the TT site were found in the case of (-)-T(6-4)T (four colonies). Mutations found at the 5[prime]-flanking site of a modified base have been reported in mammalian cells (39,40,45,46). Although the precise mechanism of this type of mutation has not been resolved, it may be caused by misincorporation of nucleotides by DNA polymerase(s), due to the local structure perturbation.

The mutation spectrum of T=T in COS-7 cells was more complex (Table 4). The mutations found most frequently were 3[prime]-T->C and 3[prime]-T->G. The 3[prime]-T->A mutation was not induced frequently. The ratios of the substitution mutations at the 3[prime]-T position to those at the 5[prime]-T site were 14:8 and 7:7 during lagging and leading strand syntheses, respectively. Thus, the mutation spectrum was affected by the strand within which the T=T was located. Interestingly, tandem mutations (5[prime]-TT->AC) were induced by T=T in COS-7 cells. The deletion of T or TT also occurred in the presence of T=T. The tandem and deletion mutations were observed more frequently with the (-)-T=T vector than the (+)-T=T vector.

These T=T mutation spectra differ from previous findings that T=T mainly induces 3[prime]-T->A and 3[prime]-T->C mutations in E.coli (47) and 3[prime]-T->A transversions in NIH3T3 cells (15). A purine-rich oligonucleotide (5[prime]-GCAAGT=TGGAG) was employed in the E.coli study (47), and the T=T lesion was located at the junction of a pyrimidine-rich sequence (5[prime]-TTCTTCT=TGGCC) in the NIH3T3 study (15). The mutation spectra of T=T may be sensitive to the sequence contexts.

Gentil et al. reported the mutational properties of T(6-4)T and T=T on ss DNA in COS-7 cells (16). They found that the MF of T(6-4)T was ~60% and that of T=T was 2.4%. These higher MFs were probably caused by the very low repair efficiencies of the two photolesions on ss DNA, and by the absence of the complementary strand. Surprisingly, they reported that >80% of the total mutations induced by T(6-4)T were G->T transversions at the 5[prime]-flanking site (16). This is in contrast to our present observation that T(6-4)T elicited targeted mutations (Table 3). Although we observed mutations at the 5[prime]-flanking site, they were minor and were found only during leading strand synthesis (Table 3). The differences in the mutational properties between our experiments and those of Gentil et al. could be attributable to differences in the replication of ss and ds vectors or to the sequence context of the adduct in the vector.

Carty et al. reported that ds plasmids containing either T(6-4)T or T=T at a predetermined site are poorly mutagenic (MFs <0.3 and 0.2 %, respectively) in in vitro DNA replication using human HeLa cell extracts (21). Moreover, they analyzed the replication efficiencies of plasmids containing T(6-4)T and T=T, and found that T(6-4)T is more inhibitory to the replication than T=T. Their results are in contrast to our present results that T(6-4)T and T=T were mutagenic, and that the plasmids containing T(6-4)T were replicated more efficiently than those containing T=T (Table 1). The reason for these discrepancies between our present study and that of Carty et al. is not clear. One possibility could be the differences in the sequence context. Alternatively, some factors necessary for bypass of the photolesions may be present in COS-7 cells, but in relatively low amounts in HeLa extracts, because COS-7 cells are green monkey cells, a natural host of the SV40 virus, and express a high level of the SV40 large tumor antigen.

Both T(6-4)T and T=T induced mutations during lagging strand synthesis more frequently than during leading strand synthesis in COS-7 cells, at least in the sequence context used in our study (Table 2). The T(6-4)T and T=T lesions induced mutations by the lagging replication apparatus 2.0 and 3.4 times, respectively, as frequently as by the leading replication apparatus. We found similar results when DNA containing oxidized adenine (2-hydroxyadenine) was replicated in COS-7 cells (25). Higher error rates during lagging strand replication in E.coli were reported by the use of a plasmid containing a single modified base at unique site (17,19), although a similar MF was reported in the case of 8-hydroxyguanine (18). Thus, it is likely that the fidelity in lagging strand synthesis may be lower than that in leading strand synthesis. The T(6-4)T and T=T lesions were less cytotoxic during lagging strand synthesis than during leading strand synthesis (Table 1). Taken together, these results indicate that the lagging strand apparatus can bypass the photolesion more easily than the leading strand apparatus, and that misincorporation of deoxynucleotides occurs during this translesional synthesis. Moreover, the mutation spectra of the two photodimers were affected by the orientation of DNA synthesis (Tables and ). Thus, the fidelities during the leading and lagging strand syntheses appear to be different, as reported in previous papers (17,19,25). Further studies with ds vectors will address the molecular mechanisms of these phenomena.

The bulky DNA lesions, T(6-4)T and T=T, induced deletions (>4 bp) in mammalian cells (Table 5). It is known that DNA polymerases are blocked in in vitro DNA synthesis with UV-irradiated DNA or an oligonucleotide containing T=T (48,49), and that the replication block appeared to cause cytotoxicity (Table 1). When T=T or T(6-4)T is present in the lagging template strand, Okazaki fragment formation around the photolesion may be inhibited. Indeed, gap formation during lagging strand synthesis was observed during in vitro SV40-origin dependent DNA synthesis with DNA containing T=T (50). When the cellular components join the two terminals of the gap, deletion mutations may occur. The enhanced frequency of deletion mutations by T=T and T(6-4)T may be derived from this mechanism, in the case of lagging strand synthesis.

It was reported that DNA synthesis is terminated by the presence of T=T in the leading template strand during in vitro SV40-origin dependent DNA synthesis (50,51). This blockage caused uncoupling of the replication fork, to generate ss regions (50,51), and the cellular components could bypass the T=T lesion after the transient replication block (51). Some of the deletions induced by T=T, and likewise T(6-4)T, in the leading template strand may be due to a `jump' of the DNA replication machinery on the template strand after the arrest.

In this study, we have shown the mutational properties of the two major photoproducts of TpT in mammalian cells. Further investigations of the properties of other photoproducts in mammalian cells will help us to understand the mechanisms of UV light-induced mutations and skin cancer.

ACKNOWLEDGEMENTS

This work was supported in part by a Grant from the University of Occupational and Environmental Health and Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan.

REFERENCES

1. Bishop, J. M. (1991) Cell, 64, 235-248. MEDLINE Abstract

2. Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J. and Ponten, J. (1991) Proc. Natl. Acad. Sci. USA, 88, 10124-10128. MEDLINE Abstract

3. Keijzer, W., Mulder, M. P., Langeveld, J. C. M., Smit, E. M. E., Bos, J. L., Bootsma, D. and Hoeijmakers, J. H. J. (1989) Cancer Res., 49, 1229-1235. MEDLINE Abstract

4. Pierceall, W. E., Kripke, M. L. and Ananthaswamy, H. N. (1992) Cancer Res., 52, 3946-3951. MEDLINE Abstract

5. Nishigori, C., Wang, S., Moyakoshi, J., Sato, M., Tsukada, T., Yagi, T., Imamura, S. and Takebe, H. (1994) Proc. Natl. Acad. Sci. USA, 91, 7189-7193. MEDLINE Abstract

6. Dumaz, N., Drougard, C., Sarasin, A. and Daya-Grosjean, L. (1993) Proc. Natl. Acad. Sci. USA, 90, 10529-10533. MEDLINE Abstract

7. Molès, J. P., Moyret, C., Guillot, B., Jeanteur, P., Guilhou, J. J., Theillet, C. and Basset-Sèguin, N. (1993) Oncogene, 8, 583-588. MEDLINE Abstract

8. Ziegler, A., Leffell, D. J., Kunala, S., Sharma, H. W., Gailani, M., Simon, J. A., Halperin, A. J., Baden, H. P., Shapiro, P. E., Bale, A. E. and Brash, D. E. (1993) Proc. Natl. Acad. Sci. USA, 90, 4216-4220. MEDLINE Abstract

9. Nataraj, A. J., Trent, J. C., II and Ananthaswamy, H. N. (1995) Photochem. Photobiol., 62, 218-230. MEDLINE Abstract

10. Matsumura Y., Nishigori, C., Yagi, T., Imamura, S. and Takebe, H. (1996) Int. J. Cancer, 65, 778-780. MEDLINE Abstract

11. Taylor, J.-S. (1995) Pure Appl. Chem., 67, 183-190.

12. Vreeswijk, M. P. G., van Hoffen, A., Westland, B. E., Vrieling, H.,van Zeeland, A. A. and Mullenders, L. H. F. (1994) J. Biol. Chem., 269, 31858-31863. MEDLINE Abstract

13. Suquet, C., Mitchell, D. L. and Smerdon, M. J. (1995) J. Biol. Chem., 270, 16507-16509. MEDLINE Abstract

14. Qin, X., Zhang, S., Zarkovic, M., Nakatsuru, Y., Shimizu, S., Yamazaki, Y., Oda, H., Nikaido, O. and Ishikawa, T. (1996) Jpn. J. Cancer Res., 87, 685-690. MEDLINE Abstract

15. Kamiya, H., Murata, N., Murata, T., Iwai, S., Matsukage, A., Masutani, C., Hanaoka, F. and Ohtsuka, E. (1993) Nucleic Acids Res., 21, 2355-2361. MEDLINE Abstract

16. Gentil, A., Page, F. Le, Margot, A., Lawrence, C. W., Borden, A. and Sarasin, A. (1996) Nucleic Acids Res., 24, 1837-1840. MEDLINE Abstract

17. Veaute, X. and Fuchs, R. P. P. (1993) Science, 261, 598-600. MEDLINE Abstract

18. Wagner, J., Kamiya, H. and Fuchs, R. P. P. (1997) J. Mol. Biol., 265, 302-309. MEDLINE Abstract

19. Kamiya, H. and Kasai, H. (1997) Nucleic Acids Res., 25, 304-311. MEDLINE Abstract

20. Thomas, D. C., Nguyen, D. C., Piegorsch, W. W. and Kunkel, T. A. (1993) Biochemistry, 32, 11476-11482. MEDLINE Abstract

21. Carty, M. P., Lawrence, C. W. and Dixon, K. (1996) J. Biol. Chem., 271, 9637-9647. MEDLINE Abstract

22. Thomas, D. C., Veaute, X., Fuchs, R. P. P. and Kunkel, T. A. (1995) J. Biol. Chem., 270, 21226-21233. MEDLINE Abstract

23. Basic-Zaninovic, T., Palombo, F. and Digliotti, E. (1992) Nucleic Acids Res., 20, 6543-6548. MEDLINE Abstract

24. Calcagnile, A., Basic-Zaninovic, T., Palombo, F. and Dogliotti, E. (1996) Nucleic Acids Res., 24, 3005-3009. MEDLINE Abstract

25. Kamiya, H. and Kasai, H. (1997) Biochemistry, 36, 11125-11130. MEDLINE Abstract

26. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Plainview, NY.

27. Iwai, S., Shimizu, M., Kamiya, H. and Ohtsuka, E. (1996) J. Am. Chem. Soc., 118, 7642-7643.

28. Murata, T., Iwai, S. and Ohtsuka, E. (1990) Nucleic Acids Res., 18, 7279-7286. MEDLINE Abstract

29. Matsuda, M., Yagi, Y., Kawanishi, M., Matsui, S. and Takebe, H. (1995) Carcinogenesis, 16, 2389-2394. MEDLINE Abstract

30. Stary, A. and Sarasin, A. (1992) J. Gen. Virol., 73, 1679-1685. MEDLINE Abstract

31. Razzaque, A., Mizusawa, H. and Seidman, M. M. (1983) Proc. Natl Acad. Sci. USA, 80, 3010-3014. MEDLINE Abstract

32. Calos, M. P., Lebkowski, J. S. and Botchan, M. R. (1983) Proc. Natl. Acad. Sci. USA, 80, 3015-3019. MEDLINE Abstract

33. Mitchell, D. L., Brash, D. E. and Nairn, R. S. (1990) Nucleic Acids Res., 18, 963-971. MEDLINE Abstract

34. Galloway, A. M., Liuzzi, M. and Paterson, M. C. (1994) J. Biol. Chem., 269, 974-980. MEDLINE Abstract

35. Qin, X., Zhang, S., Oda, H., Nakatsuru, Y., Shimizu, S., Yamazaki, Y., Nikaido, O. and Ishikawa, T. (1995) Jpn. J. Cancer Res., 86, 1041-1048. MEDLINE Abstract

36. Szymkowski, D. E., Lawrence, C. W. and Wood, R. D. (1993) Proc. Natl. Acad. Sci. USA, 90, 9823-9827. MEDLINE Abstract

37. Thomas, D. C. and Kunkel, T. A. (1993) Proc. Natl. Acad. Sci. USA, 90, 7744-7748. MEDLINE Abstract

38. Carty, M. P., Hauser, J., Levine, A. S. and Dixon, K. (1993) Mol. Cell. Biol., 13, 533-542. MEDLINE Abstract

39. Kamiya, H., Miura, K., Ishikawa, H., Inoue, H., Nishimura, S. and Ohtsuka, E. (1992) Cancer Res., 52, 3483-3485. MEDLINE Abstract

40. Kamiya, H., Murata-Kamiya, N., Koizume, S., Inoue, H., Nishimura, S. and Ohtsuka, E. (1995) Carcinogenesis, 16, 883-889. MEDLINE Abstract

41. Gibbs, P. E. M., Borden, A. and Lawrence, C. W. (1995) Nucleic Acids Res., 23, 1919-1922. MEDLINE Abstract

42. LeClerc, J. E., Borden, A. and Lawrence, C. W. (1991) Proc. Natl. Acad. Sci. USA, 88, 9685-9689. MEDLINE Abstract

43. Smith, C. A., Wang, M., Jiang, N., Che, L., Zhao, X. and Taylor J.-S. (1996) Biochemistry, 35, 4146-4154. MEDLINE Abstract

44. Fujiwara, Y. and Iwai, S. (1997) Biochemistry, 36, 1544-1550. MEDLINE Abstract

45. Kamiya, H., Suzuki, M., Komatsu, Y., Miura, H., Kikuchi, K., Sakaguchi, T., Murata, N., Masutani, C., Hanaoka, F. and Ohtsuka, E. (1992) Nucleic Acids Res., 20, 4409-4415. MEDLINE Abstract

46. Bishop, R. E., Pauly, G. T. and Moschel, R. C. (1996) Carcinogenesis, 17, 849-856. MEDLINE Abstract

47. Lawrence, C. W., Banerjee, S. K., Borden, A. and LeClerc, J. E. (1990) Mol. Gen. Genet., 222, 166-168. MEDLINE Abstract

48. Moore, P. D., Bose, K. K., Rabkin, S. D. and Strauss, B. S. (1981) Proc. Natl. Acad. Sci. USA, 78, 110-114. MEDLINE Abstract

49. Taylor, J.-S. and O'day, C. L. (1990) Biochemistry, 29, 1624-1632. MEDLINE Abstract

50. Svoboda, D. L. and Vos, J.-M. H. (1995) Proc. Natl. Acad. Sci. USA, 92, 11975-11979. MEDLINE Abstract

51. Cordeiro-Stone, M., Zaritskaya, L. S., Price, L. K. and Kaufmann, W. K. (1997) J. Biol. Chem., 272, 13945-13954. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +81 93 691 7469; Fax: +81 93 601 2199; Email: hirokam@med.uoeh-u.ac.jp


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 19 May 1998
Copyright©Oxford University Press, 1998.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Higurashi, T. Ohtsuki, A. Inase, R. Kusumoto, C. Masutani, F. Hanaoka, and S. Iwai
Identification and Characterization of an Intermediate in the Alkali Degradation of (6-4) Photoproduct-containing DNA
J. Biol. Chem., December 19, 2003; 278(51): 51968 - 51973.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Stary, P. Kannouche, A. R. Lehmann, and A. Sarasin
Role of DNA Polymerase {eta} in the UV Mutation Spectrum in Human Cells
J. Biol. Chem., May 23, 2003; 278(21): 18767 - 18775.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. Prakash and L. Prakash
Translesion DNA synthesis in eukaryotes: A one- or two-polymerase affair
Genes & Dev., August 1, 2002; 16(15): 1872 - 1883.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Mizukoshi, T. S. Kodama, Y. Fujiwara, T. Furuno, M. Nakanishi, and S. Iwai
Structural study of DNA duplexes containing the (6-4) photoproduct by fluorescence resonance energy transfer
Nucleic Acids Res., December 15, 2001; 29(24): 4948 - 4954.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
Z. Wang
DNA DAMAGE-INDUCED MUTAGENESIS : A NOVEL TARGET FOR CANCER PREVENTION
Mol. Interv., December 1, 2001; 1(5): 269 - 281.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
M. Tanaka, S. Nakajima, M. Ihara, T. Matsunaga, O. Nikaido, and K. Yamamoto
Effects of photoreactivation of cyclobutane pyrimidine dimers and pyrimidine (6-4) pyrimidone photoproducts on ultraviolet mutagenesis in SOS-induced repair-deficient Escherichia coli
Mutagenesis, January 1, 2001; 16(1): 1 - 6.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. Zhang, F. Yuan, X. Wu, O. Rechkoblit, J.-S. Taylor, N. E. Geacintov, and Z. Wang
Error-prone lesion bypass by human DNA polymerase {eta}
Nucleic Acids Res., December 1, 2000; 28(23): 4717 - 4724.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Otoshi, T. Yagi, T. Mori, T. Matsunaga, O. Nikaido, S.-T. Kim, K. Hitomi, M. Ikenaga, and T. Todo
Respective Roles of Cyclobutane Pyrimidine Dimers, (6-4)Photoproducts, and Minor Photoproducts in Ultraviolet Mutagenesis of Repair-deficient Xeroderma Pigmentosum A Cells
Cancer Res., March 1, 2000; 60(6): 1729 - 1735.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y.-H. You, D.-H. Lee, J.-H. Yoon, S. Nakajima, A. Yasui, and G. P. Pfeifer
Cyclobutane Pyrimidine Dimers Are Responsible for the Vast Majority of Mutations Induced by UVB Irradiation in Mammalian Cells
J. Biol. Chem., November 21, 2001; 276(48): 44688 - 44694.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (86K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Kamiya, H.
Right arrow Articles by Kasai, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamiya, H.
Right arrow Articles by Kasai, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?